Shahin Hatamian, senior vice president of product management at Mitchell, believes the use of data and analytics have seen major innovation in the industry.
Expanded utilization review helped a self-insured employer control rising surgical costs, reduce unnecessary procedures, and generate over $1M in savings while maintaining a two-day review turnaround.
See Michele Hibbert break down the impact of new state legislation on AI-powered claims processes in this exclusive Business Insurance "Comp Spotlight" interview.
Read how New York's strategic utilization review expansion kept medical payments stable despite rising costs nationwide.
Discover how to prevent Medicare from disrupting your settled claims. Learn when MSAs are needed, what documentation to gather upfront, and strategic approaches to identify cost drivers.
As the workforce ages, workers’ comp claims grow more complex. Enlyte experts share insights on case management, ergonomics, and return to work strategies.
Gabapentin was approved by the Food and Drug Administration (FDA) decades ago for seizures and nerve pain. Today, it is one of the most commonly prescribed drugs in the United States.